Ovarian cancer (OC) is one of the deadliest gynecological malignancies and ranks fifth in cancer-related deaths among women [1]. Epithelial ovarian cancer is the most important histological subtype, accounting for approximately 90 % of ovarian cancer, with High-Grade Serous Carcinoma (HGSC) being the most common type [2]. Due to the occult symptomatic progression of the disease, most patients are diagnosed at advanced stages with FIGO stage III–IV. For these advanced stage patients, chemotherapy…